Related references
Note: Only part of the references are listed.Newborn screening for Morquio disease and other lysosomal storage diseases: results from the 8-plex assay for 70,000 newborns
Yin-Hsiu Chien et al.
ORPHANET JOURNAL OF RARE DISEASES (2020)
Cardiac Evaluation Using Two-Dimensional Speckle-Tracking Echocardiography and Conventional Echocardiography in Taiwanese Patients with Mucopolysaccharidoses
Hsiang-Yu Lin et al.
DIAGNOSTICS (2020)
Abnormally increased carotid intima media-thickness and elasticity in patients with Morquio A disease
Raymond Y. Wang et al.
ORPHANET JOURNAL OF RARE DISEASES (2020)
Aortic root dilatation in patients with mucopolysaccharidoses and the impact of enzyme replacement therapy
Fabiano de Oliveira Poswar et al.
HEART AND VESSELS (2019)
Therapeutic Options for Mucopolysaccharidoses: Current and Emerging Treatments
Kazuki Sawamoto et al.
DRUGS (2019)
Cardiac characteristics and natural progression in Taiwanese patients with mucopolysaccharidosis III
Hsiang-Yu Lin et al.
ORPHANET JOURNAL OF RARE DISEASES (2019)
An At-Risk Population Screening Program for Mucopolysaccharidoses by Measuring Urinary Glycosaminoglycans in Taiwan
Hsiang-Yu Lin et al.
DIAGNOSTICS (2019)
Taiwan National Newborn Screening Program by Tandem Mass Spectrometry for Mucopolysaccharidoses Types I, II, and VI
Min-Ju Chan et al.
JOURNAL OF PEDIATRICS (2019)
Status of newborn screening and follow up investigations for Mucopolysaccharidoses I and II in Taiwan
Chih-Kuang Chuang et al.
ORPHANET JOURNAL OF RARE DISEASES (2018)
Clinical characteristics and surgical history of Taiwanese patients with mucopolysaccharidosis type II: data from the hunter outcome survey (HOS)
Hsiang-Yu Lin et al.
ORPHANET JOURNAL OF RARE DISEASES (2018)
Mucopolysaccharidosis III in Taiwan: Natural history, clinical and molecular characteristics of 28 patients diagnosed during a 21-year period
Hsiang-Yu Lin et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2018)
Cardiac features and effects of enzyme replacement therapy in Taiwanese patients with Mucopolysaccharidosis IVA
Hsiang-Yu Lin et al.
ORPHANET JOURNAL OF RARE DISEASES (2018)
The relationships between urinary glycosaminoglycan levels and phenotypes of mucopolysaccharidoses
Hsiang-Yu Lin et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2018)
Angiotensin receptor blockade mediated amelioration of mucopolysaccharidosis type I cardiac and craniofacial pathology
Mark J. Osborn et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2017)
Losartan improves aortic dilatation and cardiovascular disease in mucopolysaccharidosis I
Esteban Alberto Gonzalez et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2017)
Aortic Dissection in Patients With Genetically Mediated Aneurysms Incidence and Predictors in the GenTAC Registry
Jonathan W. Weinsaft et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Causes of death and clinical characteristics of 34 patients with Mucopolysaccharidosis II in Taiwan from 1995-2012
Hsiang-Yu Lin et al.
ORPHANET JOURNAL OF RARE DISEASES (2016)
Heart and Cardiovascular Involvement in Patients with Mucopolysaccharidosis Type IVA (Morquio-A Syndrome)
Christoph Kampmann et al.
PLOS ONE (2016)
Aortic Root Dilatation in Mucopolysaccharidosis I-VII
Meena Bolourchi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Bias Related to Body Mass Index in Pediatric Echocardiographic Z Scores
Frederic Dallaire et al.
PEDIATRIC CARDIOLOGY (2015)
The anatomy of the aging aorta
Jarrod A. Collins et al.
CLINICAL ANATOMY (2014)
Cardiovascular abnormalities in Taiwanese patients with mucopolysaccharidosis
Shan-Miao Lin et al.
MOLECULAR GENETICS AND METABOLISM (2014)
Natural history and clinical assessment of Taiwanese patients with mucopolysaccharidosis IVA
Hsiang-Yu Lin et al.
ORPHANET JOURNAL OF RARE DISEASES (2014)
A modified liquid chromatography/tandem mass spectrometry method for predominant disaccharide units of urinary glycosaminoglycans in patients with mucopolysaccharidoses
Chih-Kuang Chuang et al.
ORPHANET JOURNAL OF RARE DISEASES (2014)
Possible Mechanical Roles of Glycosaminoglycans in Thoracic Aortic Dissection and Associations with Dysregulated Transforming Growth Factor-beta
J. D. Humphrey
JOURNAL OF VASCULAR RESEARCH (2013)
Causes and histopathology of ascending aortic disease in children and young adults
Deepali Jain et al.
CARDIOVASCULAR PATHOLOGY (2011)
Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management
Elizabeth A. Braunlin et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2011)
Pathogenesis of aortic dilatation in mucopolysaccharidosis VII mice may involve complement activation
Guilherme Baldo et al.
MOLECULAR GENETICS AND METABOLISM (2011)
Upregulation of elastase activity in aorta in mucopolysaccharidosis I and VII dogs may be due to increased cytokine expression
Jason A. Metcalf et al.
MOLECULAR GENETICS AND METABOLISM (2010)
Mortality and cause of death in mucopolysaccharidosis type II-a historical review based on data from the Hunter Outcome Survey (HOS)
S. A. Jones et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2009)
The mild form of mucopolysaccharidosis type I (Scheie syndrome) is associated with increased ascending aortic stiffness
Attila Nemes et al.
HEART AND VESSELS (2008)
Upregulation of elastase proteins results in aortic dilatation in mucopolysaccharidosis I mice
Xiucui Ma et al.
MOLECULAR GENETICS AND METABOLISM (2008)
Validation and re-evaluation of a discriminant model predicting anatomic suitability for biventricular repair in neonates with aortic stenosis
SD Colan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Mucopolysaccharidosis I under enzyme replacement therapy with laronidase - A mortality case with autopsy report
HY Lin et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2005)
Impaired elastogenesis in Hurler disease - Dermatan sulfate accumulation linked to deficiency in elastin-binding protein and elastic fiber assembly
A Hinek et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Share Paper
